Abivax SA
Healthcare · EUR · F
Price
€106.957
Cap
€7.65B
Earnings
—
30d Trend
+10.8%
51% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 56×Macro 0.99 (−1%)=55
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
5-day catalyst play — earnings window
BRAIN47'S ASSESSMENT
I rate Abivax SA at 55/100 — a STRONG reading on the Brain47 Signal. The strongest factor is technical at 63/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
+21.4%
3 MONTHS
+10.6%
12 MONTHS
+2070.2%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
5-day catalyst play — earnings window. Technical (63) and Quality (62) are the primary strengths. I note that fundamentals is the weakest area at 15/100 — this warrants monitoring. Historical volatility is elevated at 51%. I classify this as a speculative position — elevated volatility at 51% and asymmetric payoff potential define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.